These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37205506)

  • 1. Inhibition of dopamine neurons prevents incentive value encoding of a reward cue: With revelations from deep phenotyping.
    Iglesias AG; Chiu AS; Wong J; Campus P; Li F; Liu ZN; Patel SA; Deisseroth K; Akil H; Burgess CR; Flagel SB
    bioRxiv; 2023 May; ():. PubMed ID: 37205506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Dopamine Neurons Prevents Incentive Value Encoding of a Reward Cue: With Revelations from Deep Phenotyping.
    Iglesias AG; Chiu AS; Wong J; Campus P; Li F; Liu ZN; Bhatti JK; Patel SA; Deisseroth K; Akil H; Burgess CR; Flagel SB
    J Neurosci; 2023 Nov; 43(44):7376-7392. PubMed ID: 37709540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurons of the Ventral Tegmental Area Encode Individual Differences in Motivational "Wanting" for Reward Cues.
    Ferguson LM; Ahrens AM; Longyear LG; Aldridge JW
    J Neurosci; 2020 Nov; 40(46):8951-8963. PubMed ID: 33046552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased Ventral Tegmental Area CB1R Signaling Reduces Sign Tracking and Shifts Cue-Outcome Dynamics in Rat Nucleus Accumbens.
    Bacharach SZ; Martin DA; Stapf CA; Sun F; Li Y; Cheer JF; Calu DJ
    J Neurosci; 2023 Jun; 43(25):4684-4696. PubMed ID: 37208179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of corticosterone on the acquisition of Pavlovian conditioned approach behavior in rats is dependent on sex and vendor.
    Turfe A; Westbrook SR; Lopez SA; Chang SE; Flagel SB
    Horm Behav; 2024 Aug; 164():105609. PubMed ID: 39083878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Which cue to 'want'? Opioid stimulation of central amygdala makes goal-trackers show stronger goal-tracking, just as sign-trackers show stronger sign-tracking.
    DiFeliceantonio AG; Berridge KC
    Behav Brain Res; 2012 May; 230(2):399-408. PubMed ID: 22391118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic Encoding of Incentive Salience in the Ventral Pallidum: Dependence on the Form of the Reward Cue.
    Ahrens AM; Ferguson LM; Robinson TE; Aldridge JW
    eNeuro; 2018; 5(2):. PubMed ID: 29740595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Examining the role of dopamine D2 and D3 receptors in Pavlovian conditioned approach behaviors.
    Fraser KM; Haight JL; Gardner EL; Flagel SB
    Behav Brain Res; 2016 May; 305():87-99. PubMed ID: 26909847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lesions of the ventral hippocampus attenuate the acquisition but not expression of sign-tracking behavior in rats.
    Fitzpatrick CJ; Creeden JF; Perrine SA; Morrow JD
    Hippocampus; 2016 Nov; 26(11):1424-1434. PubMed ID: 27438780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of corticosterone on the acquisition of Pavlovian conditioned approach behavior is dependent on sex and vendor.
    Turfe A; Westbrook SR; Lopez SA; Chang SE; Flagel SB
    bioRxiv; 2024 Mar; ():. PubMed ID: 38562896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Environmental manipulations alter age differences in attribution of incentive salience to reward-paired cues.
    Anderson RI; Bush PC; Spear LP
    Behav Brain Res; 2013 Nov; 257():83-9. PubMed ID: 24050888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lesions of the paraventricular nucleus of the thalamus differentially affect sign- and goal-tracking conditioned responses.
    Haight JL; Fraser KM; Akil H; Flagel SB
    Eur J Neurosci; 2015 Oct; 42(7):2478-88. PubMed ID: 26228683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tendency to sign-track predicts cue-induced reinstatement during nicotine self-administration, and is enhanced by nicotine but not ethanol.
    Versaggi CL; King CP; Meyer PJ
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):2985-97. PubMed ID: 27282365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The paraventricular thalamus is a critical mediator of top-down control of cue-motivated behavior in rats.
    Campus P; Covelo IR; Kim Y; Parsegian A; Kuhn BN; Lopez SA; Neumaier JF; Ferguson SM; Solberg Woods LC; Sarter M; Flagel SB
    Elife; 2019 Sep; 8():. PubMed ID: 31502538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potential role for the paraventricular nucleus of the thalamus in mediating individual variation in Pavlovian conditioned responses.
    Haight JL; Flagel SB
    Front Behav Neurosci; 2014; 8():79. PubMed ID: 24672443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-lasting contribution of dopamine in the nucleus accumbens core, but not dorsal lateral striatum, to sign-tracking.
    Fraser KM; Janak PH
    Eur J Neurosci; 2017 Aug; 46(4):2047-2055. PubMed ID: 28699296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural Activity in the Ventral Pallidum Encodes Variation in the Incentive Value of a Reward Cue.
    Ahrens AM; Meyer PJ; Ferguson LM; Robinson TE; Aldridge JW
    J Neurosci; 2016 Jul; 36(30):7957-70. PubMed ID: 27466340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toward isolating the role of dopamine in the acquisition of incentive salience attribution.
    Chow JJ; Nickell JR; Darna M; Beckmann JS
    Neuropharmacology; 2016 Oct; 109():320-331. PubMed ID: 27371135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cue and Reward Evoked Dopamine Activity Is Necessary for Maintaining Learned Pavlovian Associations.
    van Zessen R; Flores-Dourojeanni JP; Eekel T; van den Reijen S; Lodder B; Omrani A; Smidt MP; Ramakers GMJ; van der Plasse G; Stuber GD; Adan RAH
    J Neurosci; 2021 Jun; 41(23):5004-5014. PubMed ID: 33888609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lateral hypothalamus and orexinergic transmission in the paraventricular thalamus promote the attribution of incentive salience to reward-associated cues.
    Haight JL; Campus P; Maria-Rios CE; Johnson AM; Klumpner MS; Kuhn BN; Covelo IR; Morrow JD; Flagel SB
    Psychopharmacology (Berl); 2020 Dec; 237(12):3741-3758. PubMed ID: 32852601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.